Raquel Conde-Alvarez

Title: Raquel Conde-Alvarez: Innovator in Vaccine Development

Introduction

Raquel Conde-Alvarez is a prominent inventor based in Pamplona, Spain. She has made significant contributions to the field of vaccine development, particularly through her innovative work with modified gram-negative bacteria. With a total of 2 patents, her research has the potential to impact public health positively.

Latest Patents

One of her latest patents involves modified gram-negative bacteria for use as vaccines. This invention relates to Gram-negative bacteria that carry an inactivated gene encoding a glycosyltransferase involved in the synthesis of the core of the lipopolysaccharide (LPS) of these bacteria. The inactivated gene results in the synthesis of a LPS with a modified core. These strains exhibit attenuated virulence while inducing sufficient humoral immunity to ensure effective vaccination of the host.

Career Highlights

Raquel has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Throughout her career, Raquel has collaborated with notable colleagues, including Jean-Pierre Gorvel and Vilma Arce Gorvel. These partnerships have enriched her research and fostered innovation in her field.

Conclusion

Raquel Conde-Alvarez is a dedicated inventor whose work in vaccine development showcases her commitment to advancing medical science. Her innovative patents and collaborations highlight her significant contributions to the field.